氟环丁烷羧酸PET偶然检出口咽癌
本文报告一例66岁男性在前列腺腺癌复发评估中,氟环丁烷羧酸PET偶然检出左侧舌根病灶,术后病理证实为浸润性鳞状细胞癌。作者据此讨论了氟环丁烷羧酸PET未来研究方向,以克服18F-氟脱氧葡萄糖在肿瘤影像中的已知局限。
要点
- 66岁男性前列腺腺癌复发评估中,氟环丁烷羧酸PET偶然检出左侧舌根病灶。
- 手术病理证实该病灶为浸润性鳞状细胞癌。
- 作者讨论了氟环丁烷羧酸PET未来研究方向以克服18F-氟脱氧葡萄糖的已知局限。
核心结论
- 氟环丁烷羧酸PET偶然检出口咽鳞状细胞癌,作者据此讨论了该示踪剂未来研究方向以克服18F-氟脱氧葡萄糖在肿瘤影像中的已知局限。
研究设计与样本
- 病例报告:一例66岁男性在前列腺腺癌复发评估中接受氟环丁烷羧酸PET检查。
主要发现
- 氟环丁烷羧酸PET检出左侧舌根病灶,手术病理证实为浸润性鳞状细胞癌。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fluorine-18-labeled 1-amino-3-fluorocyclobutane-1-carboxylic acid (fluciclovine) is a synthetic amino acid radiopharmaceutical initially developed to improve noninvasive diagnosis of gliomas and currently FDA approved for prostate cancer imaging. Although fluciclovine positron emission tomography (PET) has proven to be efficacious in detecting multiple types of cancer, its ability to detect oropharyngeal squamous cell carcinoma (OPSCC) is largely unknown. METHODS: We describe a case of incidental OPSCC detection with fluciclovine PET in a 66-year old male patient during workup for recurrent prostate adenocarcinoma. RESULTS: Fluciclovine PET detected a left base of tongue (BOT) lesion, which was subsequently confirmed as invasive SCC on surgical pathology. CONCLUSION: Given these findings, we discuss potential future directions for research with fluciclovine to overcome some of the known limitations of 18 [F]fluorodeoxyglucose in oncological imaging.
引用
- Jethanandani A, Chen MM, Gule-Monroe MK, et al. Incidental detection of oropharyngeal cancer with fluciclovine PET. Head Neck. 2019. PMID: 31046173. doi:10.1002/hed.25798
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。